Postpartum Pharmacokinetics of Peramivir in the Treatment of 2009 H1N1 Influenza

Abstract

The pharmacokinetic parameters in this patient were unexpected because the clearances occurred more quickly than in phase I trials. These differences highlight the need for additional pharmacokinetic reporting of peramivir in pregnant and postpartum women.